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ABSTRACT
Purpose. This study was designed to examine the feasi-
bility of combining lymphoscintigraphy and intraoperative
sentinel node identiﬁcation in patients with head and neck
melanoma by using a hybrid protein colloid that is both
radioactive and ﬂuorescent.
Methods. Eleven patients scheduled for sentinel node
biopsy in the head and neck region were studied. Approx-
imately 5 h before surgery, the hybrid nanocolloid labeled
with indocyanine green (ICG) and technetium-99m (
99mTc)
was injected intradermally in four deposits around the scar
of the primary melanoma excision. Subsequent lympho-
scintigraphy and single photon emission computed
tomography with computed tomography (SPECT/CT) were
performed to identify the sentinel nodes preoperatively. In
the operating room, patent blue dye was injected in 7 of the
11 patients. Intraoperatively, sentinel nodes were acousti-
cally localized with a gamma ray detection probe and
visualized by using patent blue dye and/or ﬂuorescence-
based tracing with a dedicated near-infrared light camera. A
portable gamma camera was used before and after sentinel
node excision to conﬁrm excision of all sentinel nodes.
Results. A total of 27 sentinel nodes were preoperatively
identiﬁed on the lymphoscintigraphy and SPECT/CT
images. All sentinel nodes could be localized intraopera-
tively. In the seven patients in whom blue dye was used,
43% of the sentinel nodes stained blue, whereas all were
ﬂuorescent. The portable gamma camera identiﬁed addi-
tional sentinel nodes in two patients. Ex vivo, all
radioactive lymph nodes were ﬂuorescent and vice versa,
indicating the stability of the hybrid tracer.
Conclusions. ICG–
99mTc-nanocolloid allows for preoper-
ative sentinel node visualization and concomitant
intraoperative radio- and ﬂuorescence guidance to the same
sentinel nodes in head and neck melanoma patients.
The intricate anatomy and the presence of several vital
structures in the neck render lymphatic mapping in this
region more difﬁcult than elsewhere.
1,2 The limited value of
vitaldyecomparedwithotherregionsmeansthatthesurgeon
has to rely mainly on the preoperative lymphoscintigraphy
and the intraoperative gamma ray detection probe.
3–5 As a
result, the sentinel node identiﬁcation rate is relatively low
and the false-negative rate is high.
6 Single photon emission
computerized tomography with computed tomography
(SPECT/CT) provides three-dimensional images and shows
the sentinel node in its anatomic habitat, facilitating the
preoperative planning of the surgical approach.
7,8 An addi-
tional intraoperative detection tool could improve the
identiﬁcation rate considerably, because sentinel nodes in
theheadandneckregionoftenarelocatedincloseproximity
tothe injectionsite and highbackground signals can hamper
sentinel node detection with the probe. A portable gamma
camera was introduced with a better spatial resolution than
the probe,and initial studiesshowedpromising resultsin the
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but this device cannot depict the surrounding anatomy.
9,10
Some surgeons, including us, prefer not to use vital blue
dyes in the face to prevent long-term tattooing effects.
11
The fact that near-infrared ﬂuorescent dyes, such as indo-
cyanine green (ICG), are invisible to the human eye avoids
this drawback.
12 Moreover, near-infrared dyes have an
improved detection sensitivity and tissue penetration,
which may facilitate the detection of a sentinel node and its
afferent lymphatic duct.
13–16 Yet like vital blue dye, ICG
migrates quickly through the lymphatic system, resulting in
a limited diagnostic time window.
17
To address the limitations of current radioguided and vital
dye-based intraoperative sentinel node detection, we devel-
oped a hybrid tracer by combining ICG and
99mTc-
nanocolloid into ICG–
99mTc-nanocolloid. This tracer is both
radioactive and ﬂuorescent and exhibits the same macro-
phage-based accumulation in lymph nodes as the
99mTc-
labeled radiocolloid.
18 It permits sentinel node detection
using conventional lymphoscintigraphy and SPECT/CT, as
well as ﬂuorescence imaging, which was initially shown in
laparoscopic sentinel node biopsy in prostate cancer
patients.
19 The current study of patients with a melanoma in
the head and neck region is the ﬁrst to explore this new
approachinopensentinelnodeprocedures.Themainpurpose
ofthestudywastoexaminewhetherthehybridtracerenables
successful lymphoscintigraphy, SPECT/CT, and intraopera-
tiveradio-and ﬂuorescenceguidancetoall the sentinelnodes
that were visualized preoperatively. A comparison to patent
blue was made in patients in whom both tracers were used.
METHODS
Patients
Patient characteristics are outlined in Table 1. Eleven
patients were prospectively enrolled after a diagnostic
excision with 2-mm margins of a melanoma in the head or
neck with a Breslow thickness of at least 1 mm or Clark
level IV. All patients were clinically node-negative (pal-
pation, ultrasound, cytology) and were scheduled for
sentinel node biopsy and reexcision of the melanoma scar.
The mean age of the patients was 54 (range 32–75) years.
The study protocol was approved by the Institutional
Review Board, and all patients were included after giving
informed consent.
Tracer Preparation
After the preparation of
99mTc-nanocolloid (GE Health-
care, Eindhoven, The Netherlands), hybrid ICG–
99mTc-
nanocolloid was formed using a dose of 0.25 mg of ICG
(ICG-Pulsion,PulsionMedicalSystems,Munich,Germany)
aspreviouslydescribed,withtheexceptionoftheadditionof
2-ml volume of saline during the
99mTc-nanocolloid prepa-
ration.
19 This adaptation was made to achieve a nanocolloid
concentration identical to the
99mTc-nanocolloid commonly
usedatourinstitution.Allprocedureswere performed under
good manufacturing practice (GMP-z) and under supervi-
sion of the institution’s pharmacist.
Tracer Administration and Preoperative Imaging
A schematic overview of the study setup is depicted in
Fig. 1. Four to 6 h before the operation, 70 MBq
ICG–
99mTc-nanocolloid in 0.4 ml was injected intrader-
mally in four deposits around the scar of the primary
melanoma excision. Anterior and lateral dynamic images
were obtained during the ﬁrst 10 min after injection using a
dual-head gamma camera (Symbia T, Siemens, Erlangen,
Germany) to visualize the lymphatic duct. Static planar
gamma camera images were acquired at 15 min and 2 h
postinjection (Fig. 2a). SPECT/CT (Symbia T) was per-
formed 2 h postinjection (Fig. 2b). After SPECT/CT
fusion, the exact location of the sentinel node(s) was
determined in relation to the surrounding anatomical
structures. A sentinel node was deﬁned as a lymph node on
a direct lymphatic drainage pathway from the primary
tumor.
20 The location of a sentinel node was marked on the
skin to provide an external focal spot for the laser pointer
of the portable gamma camera during the operation.
Surgical Procedure
Sentinelnodebiopsyandreexcisionofthemelanomascar
started within 6 h after injection of the tracer. Immediately
beforetheoperation,ameanvolumeof1.0 mlofpatentblue
dye (Laboratoire Guerbet, Aulnay-Sous-Bois, France) was
injected intradermally at the primary tumor site in the seven
patients with melanoma located outside the facial area.
Subsequently, the sentinel nodes were visualized using a
portable gamma camera (Sentinella, Oncovision, Valencia,
Spain) to decide on the location for the incision(s) (Fig. 2c,
d). Image acquisition times ranged from 30 s to 1 min in
accordance with previous reports.
10 After incision, the sen-
tinel nodes were initially pursued with a hand-held gamma
raydetectionprobe(Neoprobe,Johnson&JohnsonMedical,
Hamburg, Germany). During surgical exploration, sentinel
nodes were visualized using either the near-infrared ﬂuo-
rescence camera system (Photodynamic eye, Hamamatsu
Photonics, Hamamatsu, Japan; Fig. 2e) or the blue dye.
Fluorescence imaging required the lights in the operating
room to be dimmed to minimize the background signal,
whereas reﬂection of the excitation light was used to visu-
alize the surrounding tissues (Fig. 2f). There are multiple
near-infrared ﬂuorescence cameras available.
21 The cost-
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tional setup time other than the time needed for sterile
draping and visualizes the ﬂuorescent signal in real-time.
Afterexcisionofasentinelnode,theportablegammacamera
was used to search for potential additional sentinel nodes as
previously described.
10 Additional sentinel nodes were
removed and second-echelon nodes were left in situ.
Ex Vivo Specimen Analysis
Quantitative ex vivo images of the excised tissue
specimens were acquired with the portable gamma
camera and with a more sensitive preclinical ﬂuorescence
camera system (IVIS200, Xenogen, Caliper Life Sci-
ences, Hopkinton, MA) to determine the radioactive and
ﬂuorescent signal intensities as described previously.
17-19
Trend line-based linear regression correlations were used
to study the correlation between the radioactive and
ﬂuorescent signal intensities. All sentinel nodes were
ﬁxed in formalin, bisected, embedded in parafﬁn, and cut
at a minimum of six levels at 50- to 150-lm intervals.
Pathologic evaluation included hematoxylin and eosin
and immunohistochemical staining using S-100 and
HMB-45.
TABLE 1 Patient characteristics, sentinel node locations, and intraoperative ﬁndings
Patient Age
(years)
Sex Melanoma
location
Breslow
(mm)
Clark
(level)
No. of
SNs on
SPECT/
CT
Location of
SNs (on
SPECT/CT)
SNs
localized
with
probe
SNs
visualized
with
gamma
camera
Blue
SNs
a
Fluorescent
SNs
Excised
SNs
R
2
1 32 Female Infraorbital
region (left)
1.6 IV 1 Level II left 1 1
a 11 –
b
2 39 Male Buccal
region (left)
2.45 III 2 Level I left, level
II left
22
a 2 2 0.79
3 70 Female Infraorbital
region
(right)
1.2 IV 3 Level I right,
level II right
Level III left
33
a 3 3 0.96
4 66 Female Infraorbital
region (left)
0.9 IV 2 Level I left, level
II left
22
a 02 –
c
5 75 Male Parietal
scalp
(medial)
2.2 V 3 Suboccipital
region left, level
II left
Level III right
3 3 0 3 3 0.98
6 50 Male Neck
(posterior
left)
1.2 IV 1 Level V left 1 2 2 2 2 0.96
7 46 Male Parietal
scalp (left)
0.9 IV 2 Occipital region
left, level V left
22 2 2 2 –
d
8 32 Female Parietal
scalp (left)
4 V 3 Level II left
(92), level V left
3 3 0 3 3 0.99
9 56 Female Parietal
scalp
(medial)
5 V 6 Level I left, level
II left, level V
left
Level I right,
level II right,
level V right
6 6 1 6 6 0.77
10 68 Female Temporal
scalp (left)
7 IV 2 Parotid region
left, level II left
1 (level
II)
2 (level
II)
2 3 3 0.9
11 56 Male Temporal
scalp (left)
2 IV 2 Parotid region
left, level II left
1 (level
II)
1 (level
II)
2 2 2 0.96
SN sentinel node, LN lymph node, R
2 correlation coefﬁcient (squared) of ex vivo radioactive/ﬂuorescent content in the excised lymph nodes
a Injection of patent blue was omitted in the four patients with a melanoma in the face
b In this patient, only one lymph node was excised, so no correlation could be calculated
c In this patient, both the radioactive/ﬂuorescent signal intensities were too weak for reliable R
2 calculation
d In this patient, no R
2 was calculated
1990 O. R. Brouwer et al.RESULTS
Characteristics and intraoperative ﬁndings of all 11
patients are outlined in Table 1. Preoperatively, conven-
tional lymphoscintigraphy and SPECT/CT visualized a
total of 27 sentinel nodes, at least 1 in each patient, with a
mean of 2.5 per patient and a maximum of 6. SPECT/CT
provided accurate anatomical reference points to plan the
surgical procedure in all patients.
Intraoperatively, the combination of radioactivity and
ﬂuorescence enabled localization and excision of all 27
preoperatively identiﬁed sentinel nodes. In patients 10 and
11, a sentinel node in the parotid gland could neither be
identiﬁed with the probe nor with the portable gamma
camera due to the overwhelming background signal from
the nearby injection site (temporal scalp, Table 1). These
sentinel nodes were localized using the ﬂuorescence cam-
era. Fluorescence imaging visualized the sentinel nodes in
10 of 11 patients. Two sentinel nodes in patient 4 could not
be visualized using the ﬂuorescence camera, these nodes
could still be localized using the portable gamma camera
and probe despite the low radioactivity count rate com-
pared with the background. Nevertheless, the more
sensitive IVIS200 ﬂuorescence camera did demonstrate a
faint ﬂuorescent signal in both nodes ex vivo. Two cases
exemplifying the penetration of the ﬂuorescent signal
through the skin but also the substantial signal attenuation
caused by a blood vessel are provided in the Supplemen-
tary information (Figs. S1–S2).
In the seven patients in whom blue dye was used, only 9
of the 21 sentinel nodes (43%) stained blue, while all were
ﬂuorescent (Table 1). In two patients, the portable gamma
camera revealed substantial residual radioactivity at the
very location from which the sentinel node had been
excised. Further exploration resulted in localization and
removal of an additional sentinel node that was blue and
ﬂuorescent in patient 6, and only ﬂuorescent in patient 10.
Preoperative lymphoscintigraphy and SPECT/CT had not
shown these sentinel nodes separately due to their close
proximity. In hindsight, the corresponding CT images
revealed two adjacent nodes at these locations (see Sup-
plementary information Fig. S3).
Ex vivo, all radioactive lymph nodes were found to be
ﬂuorescent and vice versa, showing a strong intensity
correlation with an average R
2 of 0.91 (Table 1). This
indicates that the tracer is stable throughout the entire
process. None of the excised lymph nodes were found to
contain metastasis at histopathological examination.
DISCUSSION
Thispilotstudydemonstratesthefeasibilityofcombining
preoperative sentinel node visualization with intraoperative
radio- and ﬂuorescence-guided sentinel node identiﬁcation
using a single injection of the hybrid tracer ICG–
99mTc-
nanocolloid in open surgery, after this approach had been
introducedinlaparoscopicprocedures.
19Thepreoperatively
observed drainage patterns and the numbers of removed
sentinel nodes were similar to the results in studies in which
99mTc-nanocolloid alone was used for lymphatic mapping,
suggesting that that hybrid tracer behaves like the original
radiocolloid.
8 Intraoperatively, ICG–
99mTc-nanocolloid
a
b
FIG. 1 Schematic overview of
the study set-up. a After
injection of ICG–
99mTc-
nanocolloid, preoperative
imaging of the sentinel nodes is
performed. Intraoperatively,
sentinel node localization is
guided by the gamma ray
detection probe, the portable
gamma camera and the near-
infrared (NIR) ﬂuorescence
camera. Postexcision gamma
camera imaging conﬁrms
complete excision of all sentinel
nodes.bIn the patients with
melanoma outside the facial
region, patent blue was
intraoperatively injected for
optical detection of blue-stained
sentinel nodes and a comparison
with ﬂuorescence imaging was
made
Hybrid Sentinel Node Biopsy in Head/Neck Melanoma 1991enabled both radioguided and optical (ﬂuorescence) guid-
ance to the very sentinel nodes depicted on the preoperative
images. Conventional techniques using optical dye(s) sepa-
rately have several disadvantages. First, small organic dyes,
such as vital blue dye or ICG alone quickly pass through the
sentinel nodes downstream to subsequent nodes, which may
be confusing and lead to the unnecessary removal of higher-
tier nodes.
17 The fast migration also may leave the sentinel
node unstained after a while.
4,5 The hybrid approach using
ICG–
99mTc-nanocolloid overcomes these drawbacks. The
ﬁnding that the radioactive and ﬂuorescent signal intensities
overlapexvivo(averageR
20.91;Table 1)illustratesthatthe
hybrid tracer remains stable throughout the entire process
andlargelyremains trappedinthesentinelnode.Thisresults
in a long intraoperative detection window of 6 h in the cur-
rent study, and we have already seen in a separate study that
the hybrid tracer is still effective after 20 h (unpublished
data).Intheheadandneckregion,lymphnodesarerelatively
FIG. 2 Combined preoperative lymphatic mapping and intraopera-
tive radio- and ﬂuorescence-guided sentinel node biopsy (patient 3,
Table 1). a Early static anterior preoperative lymphoscintigram at
10 min after infraorbital peritumoral injection of ICG–
99mTc-nano-
colloid showing the injection site (T) with lymphatic drainage to two
sentinel nodes in the neck on the right (R) side and a third one on the
left (L) side (arrows). b 3D SPECT/CT image 2 h postinjection
providing additional anatomical information with visualization of a
lymphatic duct (arrow) originating from the injection site (T).
c, d Intraoperatively, the radioactive component of the hybrid tracer
in the left sentinel node is visualized using a portable gamma camera,
and its laser pointer guides placement of the incision. e, f A near-
infrared ﬂuorescence camera is used to visualize the ﬂuorescent
component of the hybrid tracer in the same (non-blue) sentinel node
1992 O. R. Brouwer et al.small (3–4 mm), frequently clustered together, and often
located close to the injection site. This renders sentinel node
localization with the probe notoriously difﬁcult. Blue or
ﬂuorescent dyes are not hampered by the background signal
coming from the injection site and enable visual identiﬁca-
tion of the sentinel node, because it stands out among a
cluster of lymph nodes and the surrounding structures. The
currentstudyconﬁrmstheﬁndingsofotherinvestigatorsthat
only a limited percentage of the sentinel nodes stain blue in
thisregion.
2, 4Inthepresentstudy,the57%ofnodesthatdid
not stain blue were all intraoperatively visualized exploiting
the ﬂuorescent signature of the hybrid tracer.
The radioactive component of the hybrid tracer enables
preoperative lymphoscintigraphy, which remains indis-
pensable to identify the sentinel node in this area of
unpredictable lymphatic drainage.
22 Furthermore, the
sequential early images are essential to identify a sentinel
(ﬁrst-echelon) node because some of the tracer may pass
through to lodge in higher-echelon nodes.
20 SPECT/CT is
of particular value for surgical planning, because it visual-
izes the complex anatomy in the neck.
8 Intraoperatively, the
sensitive portable gamma camera enables the surgeon to
obtain an image depicting all radioactive hot spots, which
can serve as an additional reference irrespective of tissue
movement or changes in patient position.
9 After removal of
the sentinel node(s), the portable gamma camera also can
help assess whether all sentinel nodes have been removed,
regardless of their location and depth.
10 Illustrating this
point, postexcision gamma ray imaging led to the identiﬁ-
cation of additional sentinel nodes in two patients in this
series, although we cannot exclude that these nodes would
have been found with the probe as well. These advantages
of gamma ray imaging cannot be replaced by ﬂuorescence
imaging, because the near-infrared light can only penetrate
a tissue layer of 1.5 cm at most.
23
Taken together, radioactivity and ﬂuorescence have
complementary properties and their combination in the
hybrid tracer ICG–
99mTc-nanocolloid facilitates sentinel
node procedures in complex areas. This approach may be
particularly valuable when sentinel nodes are located close
to the injection site and in regions where small organic
dyes, such as patent blue, are of limited value.
CONCLUSIONS
A single injection of the hybrid tracer ICG–
99mTc-nano-
colloid enables preoperative sentinel node visualization and
concomitant intraoperative radio- and ﬂuorescence-guid-
ance to the same sentinel nodes in head and neck melanoma
patients. The ﬂuorescent component in this hybrid approach
offers a more generous time window than the currently used
blue dye; it can be visualized through a layer of tissue and
allowsforopticaldetectionofsentinelnodesthatdonotstain
blue. A larger study is in progress to substantiate these pre-
liminary ﬁndings.
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